Key facts
- betterview (Clinics/Outpatient Services)’s last known valuation is $51.9M (Dec 2024).
- It has raised $14.6M; the latest was Early Stage VC ($4.9M) in Dec 2024.
- Notable investors include Fair VC.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for betterview (Clinics/Outpatient Services)
- ·The full record, as it builds
Funding rounds
No funding rounds for betterview (Clinics/Outpatient Services) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About betterview (Clinics/Outpatient Services)
Provider of ophthalmic surgical treatments intended to correct visual impairments and reduce dependency on corrective eyewear. The company offers a spectrum of advanced laser and lens implantation procedures supported by a structured patient care framework, enabling individuals to experience visual freedom.
- Sector
- Healthcare
- HQ
- Winterthur, Switzerland
- Founded
- 2021
- Employees
- 83
- Website
- betterview.ch/
- Ownership
- Privately Held (backing)
betterview (Clinics/Outpatient Services) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in betterview (Clinics/Outpatient Services) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on betterview (Clinics/Outpatient Services) in its N-PORT filings yet. We sweep new filings monthly.